1,2-二烯丙基肼 | 26072-79-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1,2-二烯丙基肼
• 英文名称: N,N'-Diallyl-hydrazin
• 英文别名: 1,2-Diallylhydrazine；1,2-bis(prop-2-enyl)hydrazine
• CAS: 26072-79-7
• 化学式: C₆H₁₂N₂
• 分子量: 112.175
• InChiKey: CEMKFIOFRQVXSS-UHFFFAOYSA-N

物化性质

• 保留指数：
  863

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  8
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  24.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1,2-二烯丙基肼 在 sodium sulfate 、 mercury(II) oxide 作用下， 以 乙醚 为溶剂， 反应 12.0h， 生成 diallyldiazene
  参考文献：
  名称：

  Bock, Hans; Berkner, Bodo, Zeitschrift fur Naturforschung, B: Chemical Sciences, 1992, vol. 47, # 11, p. 1551 - 1560

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2-Diallyl-hydrazindicarbonsaerediethylester 在 氢氧化钾 作用下， 以 乙二醇 为溶剂， 反应 1.0h， 生成 1,2-二烯丙基肼
  参考文献：
  名称：

  Bock, Hans; Berkner, Bodo, Zeitschrift fur Naturforschung, B: Chemical Sciences, 1992, vol. 47, # 11, p. 1551 - 1560

  摘要：

  DOI：

文献信息

• CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS WITH ENDOGENOUS GROUPS
  申请人：Savage Paul B.

  公开号：US20210363174A1

  公开（公告）日：2021-11-25

  Cationic steroidal antimicrobial (CSA) compounds having a structure of Formula I, II or III, or salt thereof, wherein at least one of R 1 -R 18 , (e.g., R 18 ) includes a terpenyl group attached via an ester or amide linkage and at least one R 1 -R 18 , (e.g., R 3 , R 7 and R 12 ) is an amino acid linked to the steroidal backbone by an ester or amide linkage: R 18 has the following structure: —R 19 —(C═O)—X—R 20 where R 19 is omitted or alkyl, alkenyl, alkynyl, or aryl, X is oxygen or nitrogen, and R 20 is a terpenyl group. R 3 , R 7 and R 12 have the following structure: R 22 R 23 N—R 21 —(C═O)—X— where R 21 is substituted or unsubstituted alkyl, X is oxygen or nitrogen, and R 22 and R 23 are independently hydrogen, alkyl, alkenyl, alkynyl, or aryl.

  具有Formula I、II或III结构的阳离子类固醇抗菌化合物（CSA），或其盐，其中R1-R18中至少有一个（例如R18）包括通过酯或酰胺键连接的萜烯基团，并且R1-R18中至少有一个（例如R3、R7和R12）是通过酯或酰胺键与类固醇骨架连接的氨基酸：R18具有以下结构：—R19—（C═O）—X—R20其中R19省略或为烷基、烯基、炔基或芳基，X为氧或氮，R20为萜烯基团。R3、R7和R12具有以下结构：R22R23N—R21—（C═O）—X—其中R21为取代或未取代的烷基，X为氧或氮，R22和R23独立地为氢、烷基、烯基、炔基或芳基。
• Pyridinium cationic lipids as gene transfer agents
  申请人：Balaban T. Alexandru

  公开号：US20050196863A1

  公开（公告）日：2005-09-08

  Pyridinium cationic lipids useful as non-viral gene delivery agents are disclosed. The agents are prepared by reaction of pyrylium salts with primary amines. Also disclosed are methods of trasfectind cells using the pyridinium cationic lipids as gene transfer agents.

  披萨是一种美味的食物，通常由面团、番茄酱、奶酪和各种配料制成。
• [EN] OLIGOMERISATION OF OLEFINIC COMPOUNDS IN AN ALIPHATIC MEDIUM<br/>[FR] OLIGOMERISATION DE COMPOSES OLEFINIQUES DANS UN MILIEU ALIPHATIQUE
  申请人：SASOL TECH PTY LTD

  公开号：WO2005123633A1

  公开（公告）日：2005-12-29

  This invention relates to a process for producing an oligomeric product by the oligomerisation of at least one olefinic compound by contacting the at least one olefinic compound with an oligomerisation catalyst in an aliphatic liquid medium at a reaction temperature of at least 50°C. The catalyst comprises the combination of a source of a transition metal; and a ligating compound of the formula (R1)m X1 (Y) X2 (R2)n.

  这项发明涉及通过将至少一种烯烃化合物与寡聚化催化剂在至少50°C的反应温度下在脂肪族液体介质中接触而产生寡聚体产品的方法。催化剂包括过渡金属的来源和一个配体化合物，其化学式为(R1)m X1 (Y) X2 (R2)n。
• Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
  申请人：AbbVie Deutschland GmbH & Co. KG

  公开号：US20150111867A1

  公开（公告）日：2015-04-23

  The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquin oline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

  本发明涉及氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物的化学式（I）或其生理耐受盐。该发明涉及包括这种氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物的药物组合物，以及利用这种氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物进行治疗目的的用途。这些氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物是GlyT1抑制剂。
• Antiviral Compounds
  申请人：Hurt Clarence

  公开号：US20120270854A1

  公开（公告）日：2012-10-25

  Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.

  提供了预防和治疗病毒感染的化合物和方法。在某些实施例中，提供了新型化合物广谱抗病毒活性。在更具体的实施例中，这些化合物和方法对委内瑞拉马蹄热病毒、西尼罗河病毒和丙型肝炎等病毒具有有效性。